New Paradigm in Treating Cancer: Right on Target

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)

Abstract

Cancer prevalence is increasing every year and now cancer is the third highest cause of death in developing countries. Effective anticancer treatment can prolong life and improve the patient's quality of life. Targeted therapy is a new therapeutic modality which targets specific molecules in the cancer cell and disrupts dysregulated signaling pathways involved in carcinogenesis. Since targeted therapy does not attack normal cells, its side effects are considered low compared to chemotherapy. More than 15 drugs have been approved for treatment in various human cancers. These drugs can largely be grouped into tyrosine kinase inhibitors and monoclonal antibodies. This review will focus on the most common agents within both groups.

Original languageEnglish
Pages (from-to)139-144
Number of pages6
JournalActa medica Indonesiana
Volume48
Issue number2
Publication statusPublished - 1 Apr 2016

Fingerprint Dive into the research topics of 'New Paradigm in Treating Cancer: Right on Target'. Together they form a unique fingerprint.

Cite this